This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
05/05/15 - 10:46:39 AM ET (BATS BZX Real-time Price)
Div Yield: --
AMRN Day's Range
AMRN 52 Week Range
AMRN Business Summary
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States.View AMRN key stats
Amarin Corp PLC - AMRN - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Amarin Corp PLC as a
Sell with a ratings score of D-.
Report Snippet: We rate AMARIN CORP (AMRN) a SELL. This is driven by a number of negative factors, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself.